“…Despite including children who were younger than 7 years old [10,11,18,25,26] in five studies using four of the six PROs found (mHHS, HHS, Iowa, Merle d'Aubigné), the papers reviewed indicated no issues in the administration of these adult PROs (Table 2). Several papers directly compared results from a PRO administered to pediatric patients with results from adult studies using the same PRO [5,10,16,23,26]. It is clear that a hip-specific PRO validated for pediatric patients in a range of conditions, including impingement, is needed to fill a gap in the range of outcome measures available to clinicians and researchers.…”